题  目: Synthetic Biology: A New Engine for the Third Wave of Biotechnology 

　　报告人：Prof. Zhao Huimin（美国伊利诺伊香槟分校Endowed Chair Professor）　　 　　 

　　时  间：2015年5月6日 10:00-11:30　　 

　　地  点：天津工业生物所 C408 报告厅 

　　报告人简介 

　　Prof. Zhao Huimin is the Centennial Endowed Chair Professor of chemical and biomolecular engineering, and professor of chemistry, biochemistry, biophysics, and bioengineering at the University of Illinois at Urbana-Champaign (UIUC).  He has authored and co-authored over 200 research articles and over 20 issued and pending patent applications with several being licensed by industry. He has received numerous research and teaching awards and honors, including Elmer Gaden Award, Guggenheim Fellowship, Fellow of the American Association for the Advancement of Science (AAAS), etc. He is the consultant for over 10 companies such as Pfizer and Gevo. Prof. Zhao is an Associate Editor of ACS Catalysis and an editor of ACS Synthetic Biology, Journal of Industrial Microbiology and Biotechnology, Scientific Reports, Biocatalysis, and Engineering in Life Sciences. His primary research interests are in the development and applications of synthetic biology tools to address society’s most daunting challenges in health, energy, and sustainability, and in the fundamental aspects of enzyme catalysis, cell metabolism, and gene regulation. 

    报告简介

　　Synthetic biology is the deliberate design of novel or improved biological systems and organisms that draws on principles elucidated by biologists, chemists, physicists, and engineers.  It is a rapidly growing area with broad applications in medical, chemical, food, and agricultural industries and particularly has become a powerful engine for the exponential growth of the industrial biotechnology industry.  In this talk, I will briefly discuss the challenges and opportunities in synthetic biology and highlight our recent work in the development and application of novel foundational synthetic biology tools.  Specifically, I will introduce the Illinois Biological Foundry for Advanced Biomanufacturing (iBioFAB) that we have been establishing and discuss its three representative biotechnological applications. The first application is the discovery, characterization, and engineering of novel natural product biosynthetic pathways for drug discovery and development.  The second is the design, construction and optimization of biochemical pathways and microbial factories for economic production of chemicals and fuels.

    新闻简讯（链接）

    海报